Treatment of Vicharchika (Eczema) by Khadirashtaka Kashaya Ghanavati and Arka Taila gel

Efficacy Of Arka Taila Gel And Khadirashtaka Kashaya Ghanavati In The Management Of Vicharchika W.S.R Of Eczema- An Open Labelled Randomized Clinical Trial.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/12/010943

Enrollment

Registered

2017-12-21

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L20-L30- Dermatitis and eczema Health Condition 2: null- Vicharchika(Eczema)

Interventions

Intervention1: Group A: Khadirashtaka Kashaya Ghanavati two Vati (each of 500mg) thrice in a day with luke warm water and Arka Taila Gel externally will be given in the patient of Vicharchika for 8 we

Eligibility

Inclusion criteria

Inclusion criteria: As per clinical signs and symptoms of Vicharchika described in classical Ayurvedic Text and eczema modern literature. Patient having symptoms like Vaivarnyata(Discoloration), Kandu (itching), Pidika (Patches), Srava (Oozing), Shyavata (Blackish colour), Rukshta (Dryness), Daha( Burning sensation), Shotha(Inflammation). Uncomplicated cases with classical signs and symptoms of Vicharchika will be selected irrespective of sex, religion, profession.

Exclusion criteria

Exclusion criteria: Disease like Diabetes mellitus, cancer, AIDS, LVH, IHD, T.B. and other systemic disorder which leads fatal condition for patient. Pregnant women

Design outcomes

Primary

Measure	Time frame
Efficacy of Arka Taila gel and Kharirashtaka Kashaya Ghanavati in VicharchikaTimepoint: 8 weeks	—

Secondary

Measure	Time frame
Safety of Arka Taila gel and Kharirashtaka Kashaya Ghanavati in VicharchikaTimepoint: 12 weeks	—

Countries

India

Contacts

Public ContactDr Alankruta R Dave

Institute for post graduate teaching and research in Ayurveda GAU Jamnagar

alankruta@yahoo.com9824171817

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026